Give cancer tissue samples to help future cancer research
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This study collects tissue or other cancer-related samples to help researchers better understand cancer and develop better tests or treatments. You can join if you are being evaluated for or treated for cancer, and you agree to let your samples be used for research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older and getting evaluated or treated for cancer at the NIH Clinical Center or a participating site
- Have newly diagnosed cancer, or cancer that has come back or is getting worse, or you are on treatment but the results haven’t been checked yet
- If your cancer is not clearly shrinking, it may still be eligible (partial response or stable disease), but the study team may need confirmation from your pathology/flow results
- Be able to understand the study and sign written consent saying you agree to have your tissue or body fluid samples used for research
- You may need to schedule sample collection as far from your most recent drug dose as possible (ideally after one treatment cycle ends and right before the next cycle starts)
- You may need to avoid certain infections and uncontrolled illness, and you cannot have HIV or active/chronic hepatitis B or C (or known past hepatitis B/C)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial helps the NIH collect and track your tissue or fluid samples used in cancer and tumor research. It may help researchers learn from your samples and medical information, but it is mainly about sample collection and data tracking.
This study collects tissue samples from patients with cancer or blood disorders, and from their matching family members who might donate stem cells for transplant. The samples help researchers understand these diseases and develop better treatments.
This study collects leftover tissue samples from patients with or without lymphoma to help researchers better understand lymph system cancers. It may be an option if you are already having a biopsy or surgery.
This study collects and stores blood/tissue samples (called biospecimens) to support immunotherapy research at the cancer center. If you may qualify, your samples help researchers test new immune-based cancer treatments.
This study collects and stores leftover or newly taken samples of tissue and blood from people with cancer. The goal is to build a research library that can help investigators study cancer and develop better tests or treatments.
This study collects tumor tissue and related blood tests from people who already need a biopsy or surgery as part of their usual care. Researchers use the samples to learn what drives the tumor and how the tumor environment may affect treatment, which could help develop future therapies.
Hear when a new Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.